Bioptic presented its gold-winning BELKA solution at NeurIPS 2024, highlighting how our AI models navigate billions of compounds to predict protein–ligand binding with precision. The work, led by Vlad Vinogradov and based on a dataset co-developed by our team, shows how AI-native tools can transform early drug discovery.
View competition
View competition
Related
Publications
BIOPTIC B1 Identifies Novel Miro1 ligands for Friedreich's ataxia — Stanford-led Cell Chemical Biology Study
Read more
BIOPTIC B1 Identifies Novel Miro1 ligands for Friedreich's ataxia — Stanford-led Cell Chemical Biology Study
Publications
BIOPTIC Agent Hunt Globally — Wide Search AI Agents for Drug Asset Scouting in Investing, Business Development, and Competitive Intelligence (arXiv, 2026)
Read more
BIOPTIC Agent Hunt Globally — Wide Search AI Agents for Drug Asset Scouting in Investing, Business Development, and Competitive Intelligence (arXiv, 2026)
Publications
BIOPTIC B1 Ultra-High-Throughput Virtual Screening System Discovers LRRK2 Ligands in Vast Chemical Space
Read more
BIOPTIC B1 Ultra-High-Throughput Virtual Screening System Discovers LRRK2 Ligands in Vast Chemical Space
Thanks for getting in touch.
We’ve received your inquiry and will follow up by email.
Your form wasn’t submitted. Please try again or email office@bioptic.io.